[Use of lactusan for the correction of microecological intestinal disturbances in children]

V E Rodoman1, V I Maksimov, L G Kuz'menko

  • 1Peoples' Friendship University, Moscow, Russia.

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|April 16, 2002
PubMed

Insights

Lactusan (lactulose) effectively treated dysbacteriosis in children, reducing diarrhea and improving gut bacteria. This prebiotic shows promise for pediatric gut health management.

Area of Science:

  • Pediatric Gastroenterology
  • Microbiology
  • Nutritional Science

Background:

  • Dysbacteriosis, an imbalance in gut microbiota, is common in children.
  • Effective treatments for pediatric dysbacteriosis are needed to improve gut health and reduce symptoms like diarrhea.

Purpose of the Study:

  • To evaluate the efficacy of lactusan (lactulose) as a treatment for dysbacteriosis in pediatric patients.
  • To assess the impact of lactulose on clinical symptoms and gut microbial composition.

Main Methods:

  • A study involving 24 sick children aged 1 month to 15 years with dysbacteriosis.
  • Administration of lactusan (lactulose) to 21 patients.
  • Monitoring of clinical symptoms, particularly diarrhea.
  • Analysis of fecal samples to assess changes in bifidobacteria, lactic acid bacteria, and opportunistic microorganisms.

Main Results:

  • Perceptible improvement in clinical symptoms, primarily cessation of diarrhea, was observed in 21 out of 24 patients.
  • Increased populations of beneficial bifidobacteria and lactic acid bacteria were noted in 14 children.
  • A decrease in the number of opportunistic microorganisms was observed in the same group of 14 children.

Conclusions:

  • Lactusan (lactulose) is an effective remedy for pediatric dysbacteriosis.
  • Lactulose administration positively modulates gut microbiota, increasing beneficial bacteria and reducing harmful ones.
  • Lactulose should be classified as a prebiotic due to its beneficial effects on gut microflora.

Related Concept Videos

Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Microbes in the Production of Fermented Foods01:27

Microbes in the Production of Fermented Foods

Lactic acid bacteria (LAB) and molds are instrumental in fermenting plant-based foods to enhance preservation and ensure year-round availability. These microbial processes convert plant carbohydrates into organic acids and other metabolites that inhibit spoilage organisms and contribute to the sensory qualities of the final product.In sauerkraut production, cabbage goes through a microbial succession that starts with cocci such as Leuconostoc mesenteroides. These microbes begin fermentation by...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...